Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

P2-225 Prostate-specific antigen testing awareness and participation in New South Wales, Australia

Demographic, lifestyle and health-related factors

Bibliographic Data

ID11180304
AuthorsDaniel A O’Connell (0000-0001-9553-2373, Cancer Council Australia), D O'Connell, L Carmichael, Lynn P Carmichael (Cancer Council Australia), Derek Smith (0000-0001-9565-1057, Cancer Council Australia), Melina Gattellari (0000-0001-7218-5356, UNSW Sydney), S Chambers (0000-0002-0991-7291), Carole Pinnock (Repatriation General Hospital), Terry Slevin (Cancer Council Western Australia), J Ward (0000-0002-2892-4542), John W Ward (0000-0001-7186-6416, University of Ottawa)
Year2011
Volume65
IssueSuppl 1
PagesA283.3-A283
Publication date2011-08-01
Peer ReviewedYes
Open AccessNo
TypeARTICLE
VenueJournal of Epidemiology and Community Health (JOURNAL)
Journal identifiersISSN: 0143-005X • E-ISSN: 1470-2738
PublisherBMJ (PUBLISHER • GB)
DOI10.1136/jech.2011.142976j.58
OpenAlexW2013769284
LanguageEN

Background Although the prostate-specific antigen (PSA) test is widely used to screen for prostate cancer, there is very little information on the characteristics of men who are aware of the PSA test, and their patterns of PSA testing. Methods A cross-sectional study used computer assisted telephone interviews to collect data in New South Wales, Australia. Multinomial logistic regression identified the factors independently associated with the awareness of, and participation in PSA testing. Results Of the 6100 men, 39% were unaware of the PSA test, 12% were aware of the PSA test but never tested, 14% had a non-recent PSA test, and 35% had a recent PSA test. Unaware men were more likely to be born outside Australia (OR=1.19; 95% CI 0.88 to 1.60), have a blue-collar occupation (OR=1.38; 95% CI 1.00 to 1.91), be a current smoker (OR=1.99; 95% CI 1.30 to 3.05), or have benign prostatic hyperplasia (BPH) (OR=1.70; 95% CI 1.07 to 2.71), and less likely to have completed a higher school certificate (OR=0.44; 95% CI 0.24 to 0.79), or live in inner regional areas (OR=0.59; 95% CI 0.44 to 0.80). Men who did not have a recent test, were more likely to visit the doctor (OR=1.38; 95% CI 1.05 to 1.82), or have BPH (OR=2.70; 95% CI 1.74 to 4.20), and were less unsure of their risk of developing prostate cancer (OR=0.61; 95% CI 0.37 to 1.00). Men who had a recent test were more likely to visit the doctor (OR=2.57; 95% CI 1.99 to 3.33), have BPH (OR=3.87; 95% CI 2.58 to 5.81), or have a higher perceived risk of developing prostate cancer (OR=1.99; 95% CI 1.22 to 3.26), and less likely to be other than married (OR=0.65; 95% CI 0.47 to 0.91). Conclusions As men's PSA testing experience varied by demographic, lifestyle and health-related factors, it is important for policymakers and physicians to consider these when communicating about PSA testing

Cancer · Cross-sectional study · Family medicine · Gynecology · Logistic regression · Multinomial logistic regression · Pathology · Prostate cancer · Prostate cancer screening · Prostate-specific antigen · Test (biology) · Demography · Internal Medicine · Medicine · Prostate Cancer Diagnosis and Treatment · Prostate Cancer Treatment and Research · Gerontology

Citation velocityhistorical
Highly citedNo
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae